Lymphocytic esophagitis
Lymphocytic esophagitis (LE) is a rare, poorly understood medical condition that affects the esophagus. It is characterized by an increased number of lymphocytes in the esophagus without the common features of gastroesophageal reflux disease (GERD).
Symptoms[edit | edit source]
The symptoms of lymphocytic esophagitis can vary greatly among patients. Some may experience no symptoms at all, while others may have severe symptoms. Common symptoms include dysphagia (difficulty swallowing), heartburn, and chest pain.
Causes[edit | edit source]
The exact cause of lymphocytic esophagitis is unknown. However, it is thought to be related to an immune response, possibly triggered by an allergy or autoimmune disease.
Diagnosis[edit | edit source]
Diagnosis of lymphocytic esophagitis is typically made through an endoscopy and biopsy of the esophagus. The presence of a high number of lymphocytes in the esophagus, without other signs of GERD, is indicative of LE.
Treatment[edit | edit source]
Treatment for lymphocytic esophagitis is largely symptomatic. This may include dietary changes, medications to reduce stomach acid, and in severe cases, corticosteroids or other immunosuppressive drugs.
Prognosis[edit | edit source]
The long-term prognosis for individuals with lymphocytic esophagitis is generally good. However, the condition can cause significant discomfort and impact quality of life. Ongoing research is needed to better understand this condition and develop more effective treatments.
See also[edit | edit source]
Lymphocytic esophagitis Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD